QualityStocksNewsBreaks Archives

TuesdaySep 17, 2019 11:40 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Adds Daniel J. Shea as Chief Financial Officer at Pivotal Time for Growth

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that Daniel J. Shea has joined the company as its senior vice president and chief financial officer effective Friday, September 13, 2019. In the key leadership position, Shea’s responsibilities will include directing and overseeing all aspects of the company’s finance and administration functions, including financial reporting and analysis; compliance with GAAP and applicable financial and tax reporting laws and rules; forecasting and budgeting; serving as primary liaison with the company’s independent accounting…

TuesdaySep 17, 2019 11:37 am

QualityStocksNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) Appoints Consumer Products and Healthcare Industry Veteran Peter Vitulli to its Board

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) this morning announced its appointment of Peter Vitulli to its board of directors. According to the update, Vitulli currently serves as an operating advisor at Windrose Health Investors and has extensive experience spanning 35 years in the consumer products and healthcare industries with both large corporations and entrepreneurial start-ups. Earlier in his career, Peter was president and general manager of the $1 billion North American Gatorade business. He most recently served as president and CEO of DNA Diagnostics Center, one of the world's largest providers of private DNA tests. "I have a long-standing…

TuesdaySep 17, 2019 11:15 am

QualityStocksNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Executives to Speak, Showcase Innate Compounds at Two Upcoming Events

INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that RJ Tesi, M.D., Co-Founder and CEO, and Mark Lowdell, Ph.D., Co-Founder and Chief Scientific Officer, will be presenting at the first ever Targeting Innate Immunity Congress. Dr. Tesi and Dr. Lowdell will also be instructing a course on the role of the tumor microenvironment (“TME”) in immunosuppression at the event, which will take place September 23rd – 25th in Cambridge, Massachusetts. INmune is set to use this opportunity to showcase its two leading innate compounds…

TuesdaySep 17, 2019 10:57 am

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate at the Eight Capital & Cassels Brock Global Cannabis Conference

Willow Biosciences Inc. (CSE: WLLW) today announced its plans to participate at the Eight Capital & Cassels Brock Global Cannabis Conference slated to be held at the Shangri-La Hotel in Toronto on September 19, 2019. Willow Biosciences will be available for one-on-one meetings during the event. In addition, Willow CEO, President and Director Trevor Peters will present in the panel, “Pushing the Boundaries Through Technology, Innovation & Research,” at 10:30 a.m. Eastern Time in the Queen's Park Ballroom. To view the full press release, visit http://ibn.fm/BdhG5 About Willow Biosciences Inc. Willow is a Canadian biotechnology company based in Calgary, Alberta,…

TuesdaySep 17, 2019 10:29 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Partners with John Legend and Casper in Nationwide Launch of 100% Hemp CBD Product Line

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in California, this morning announced the nationwide launch of its first-ever 100% hemp CBD product line. According to the update, a newly established brand partnership between PLUS and American superstar and philanthropist John Legend supports the launch, and Legend will advocate on behalf of the company’s new nationwide hemp CBD product offering. “I have been a believer in the benefits of CBD for some time,” stated Legend. “I was drawn to the PLUS team because they're an innovative, family-run company, and they use science to deliver a consistent,…

TuesdaySep 17, 2019 10:17 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Announces Partnership with Linneo Health to Supply Medical Cannabis in Europe

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced that it has engaged with Linneo Health S.L., a subsidiary of Alcaliber S.A., to be its European medical cannabis supply partner. A European leader in the pharmaceutical cannabis industry, Linneo Health recently received its EU-GMP (“Good Manufacturing Practices”) certification from the Spanish regulatory authorities. According to the update, the multi-year agreement includes increasing supply volumes as VIVO expands in the European medical market. "Our partnership with Linneo Health is part of our strategic priority to accelerate international market growth," VIVO CEO Barry Fishman said in the news release. "We are…

TuesdaySep 17, 2019 10:03 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Enters Distribution Agreement to Launch Medical Cannabis Inhaler in Canada

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered into a distribution agreement with Israel-based pharma-tech company Syqe Medical, Ltd. to launch Syqe's flagship product, the Syqe(TM) Inhaler, in Canada. The Syqe Inhaler is a metered-dose medical cannabis inhaler that provides quick pain relief while decreasing psychoactive effects and enabling patients to go about their normal daily activities. The inhaler’s use of metered dosing allows patients and healthcare providers to consistently deliver treatment at pharmaceutical standards. Through its wholly owned subsidiaries, TerrAscend…

TuesdaySep 17, 2019 9:48 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human CBD Study Results Published in Peer Reviewed Clinical Journal

Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced the publication of final study results of the 2018 human clinical study evaluating CBD delivery and effectiveness using its patented DehydraTECH(TM) powered TurboCBD(TM); capsules. According to the update results were published in the peer reviewed medical journal, Advances in Therapy, which focuses on clinical medicine and pharmaceutical research and has been published continually since 1984. Lexaria reported several key findings highlighted in the publication, including but not limited to: CBD in-plasma levels with the 90mg dose of TurboCBD were significantly higher than with the generic…

TuesdaySep 17, 2019 9:22 am

QualityStocksNewsBreaks – Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Reports Positive Mineral Process Recovery Test Results

Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) today announced results from mineral process recovery testing on material from its flagship nickel/cobalt development-focused Cyclops Project as reported by its independent extractive technology and mineral process development partner. Per the update, the first phase of the detailed bench scale program, which is intended to evaluate separation technology on samples of materials from several geological profiles, has been completed. The samples were leached using PCRCF’s partner’s proprietary mixed chloride technology. The results demonstrated the efficacy of the mixed chloride leach technology in the recovery of value elements, specifically nickel, and cobalt…

MondaySep 16, 2019 11:10 am

QualityStocksNewsBreaks – ChineseInvestors.com Inc. (CIIX) to Present at the MicroCap Conference in New York City on September 17

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today announced that CFO Alex P. Hamilton of its subsidiary, CBD Biotech, Inc., is scheduled to present at the MicroCap Conference. The exclusive event, dedicated to connecting small and micro-cap companies with high-level, institutional and retail investors, is slated to be held at the JW Marriot Essex House in New York City on September 16 -17, 2019. CIIX’s presentation is scheduled for Tuesday, September 17, 2019, at 1:00 p.m. Eastern Time in Room 1. To view the full press release, visit http://ibn.fm/aaS7r About ChineseInvestors.com Founded in…

Site Search

Company Search

Category: QualityStocksNewsBreaks